Mumps

Common Name(s)

Mumps

Mumps are a contagious disease caused by a virus. Mumps are spread when an infected person sneezes, coughs, or talks. It can also be spread through contact such as from touching a tissue or utensil that an infected person has touched or used. Symptoms typically appear 2-3 weeks after a person has been exposed to the virus, and include swelling of the cheeks and jaw from inflammation of the saliva glands, as well as fever, headache, stiff neck, and loss of appetite. Mumps can sometimes cause serious problems in the heart, pancreas, and joints, and can also lead to meningitis and encephalitis (inflammation of the brain). A vaccine for mumps is available.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Mumps" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Mumps" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Mumps" returned 645 free, full-text research articles on human participants. First 3 results:

The pathogenesis of iodide mumps: A case report.
 

Author(s): Guilian Zhang, Tao Li, Heying Wang, Jiao Liu

Journal: Medicine (Baltimore). 2017 Nov;96(47):e8881.

 

Iodide mumps is an uncommon condition, induced by iodide-containing contrast, and is characterized by a rapid, painless enlargement of the bilateral or unilateral salivary gland. At present, the pathogenesis of iodide mumps is not yet clear. It may be related to an idiosyncratic reaction, ...

Last Updated: 31 Dec 1969

Go To URL
Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak.
 

Author(s): Mona Marin, Mariel Marlow, Kelly L Moore, Manisha Patel

Journal:

 

A substantial increase in the number of mumps outbreaks and outbreak-associated cases has occurred in the United States since late 2015 (1,2). To address this public health problem, the Advisory Committee on Immunization Practices (ACIP) reviewed the available evidence and determined ...

Last Updated: 31 Dec 1969

Go To URL
Campaign Mode MMR Vaccination to Control Outbreak of Mumps in a Highly Vaccinated Population: Virologist's viewpoint.
 

Author(s): V G Ramachandran

Journal: Indian Pediatr. 2017 12;54(12):1050-1051.

 

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Mumps" returned 24 free, full-text review articles on human participants. First 3 results:

A New Combined Vaccine Against Measles, Mumps, Rubella and Varicella in India.
 

Author(s): Nitin Shah, Raunak Parikh, Giacomo Casabona, Shafi Kolhapure

Journal: Indian Pediatr. 2017 12;54(12):1041-1046.

 

A quadrivalent MMRV (measles-mumps-rubella-varicella) combination vaccine has recently been launched in India. This vaccine is highly immunogenic, with seroconversion rates against all antigens reaching 96.6-100% at 42 to 56 days after the second vaccine dose in unvaccinated children ...

Last Updated: 31 Dec 1969

Go To URL
Pain caused by measles, mumps, and rubella vaccines: A systematic literature review.
 

Author(s): Corinne Willame, Ouzama Henry, Lan Lin, Volker Vetter, Laurence Baril, Nicolas Praet

Journal: Vaccine. 2017 10;35(42):5551-5558.

 

The risk of post-vaccination adverse events (AEs) is a primary public health concern. Among the AEs, pain is a significant source of anxiety for both children and their parents. This review describes and assesses the intensity of pain experienced by children post-vaccination with ...

Last Updated: 31 Dec 1969

Go To URL
Epidemiology and economic burden of measles, mumps, pertussis, and varicella in Germany: a systematic review.
 

Author(s): Oliver Damm, Julian Witte, Stefanie Wetzka, Christine Prosser, Sebastian Braun, Robert Welte, Wolfgang Greiner

Journal: Int J Public Health. 2016 Sep;61(7):847-60.

 

Despite the availability of vaccines and the existence of public vaccination recommendations, outbreaks of vaccine-preventable childhood diseases still cause public health debate. The objective of this systematic review was to provide an overview of the current epidemiology and economic ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Last Updated: 21 Feb 2018

Go to URL
Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines
 

Status: Recruiting

Condition Summary: Vaccine Response Impaired

 

Last Updated: 7 Dec 2017

Go to URL
Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant
 

Status: Recruiting

Condition Summary: RENAL INSUFFICIENCY, CHRONIC; LIVER FAILURE, ACUTE; HEART DISEASE

 

Last Updated: 5 May 2018

Go to URL